RARRES2P6

Across TCGA pan-cancer cohorts, RARRES2P6 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RARRES2P6 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RARRES2P6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RARRES2P6 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

COAD, BLCA, and THCA are the cancer types where RARRES2P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.155	0.683	<.001	81	view →
BLCA	OS	Tertile	III,IV	0.212	0.498	.002	78	view →
THCA	DFS	Tertile	III,IV	0.626	0.904	<.001	69	view →
KICH	OS	Tertile	II,III,IV	0.070	0.828	<.001	63	view →
BRCA	OS	Tertile	IV	0.106	0.791	<.001	36	view →
STAD	OS	Tertile	II,III,IV	0.586	0.706	.016	29	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
ESCA	OS	Tertile	III,IV	0.701	0.353	.028	16	view →
LUSC	DFS	Tertile	III,IV	0.329	0.812	.019	12	view →
ACC	OS	Tertile	IV	0.251	0.776	.009	9	view →
PCPG	OS	Tertile	All	0.770	0.965	.046	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RARRES2P6–COAD (OS)

Open the COAD breakdown →